Delivery Order SPE2DX22D0020-SPE2D826F05EE
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $70,561.85 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This competitive award, issued on September 29, 2025, with a completion date of September 30, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. The order represents a child contract under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $53,510.73 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed price delivery order, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $13,364.95 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed price delivery order, awarded on October 6, 2025, with an ultimate completion date of October 7, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $24,903.00 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed price delivery order, issued on June 30, 2025, with a completion date of July 1, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. This firm fixed price delivery order, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a non-set-aside, competitively awarded contract. The award is a child contract under...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $7,797.33 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a competitive award with no set-aside designation. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $10,143.87 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, issued on September 8, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $28,510.40 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This non-competitive delivery order, issued on September 29, 2025, with a completion date of September 30, 2025, is structured as a firm fixed price contract. The award is a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC)...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $7,683.97 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, issued on June 30, 2025, with an ultimate completion date of July 1, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $68,633.28 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This contract, awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, represents a firm fixed-price delivery order with no set-aside designation. The award was competitively procured and will be performed at the contractor's...
- SPE2DX22D0020Indefinite Delivery Contract
- SPE2DX22D0020-SPE2D826F05EEDelivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $11,248.75 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This competitive award, issued on November 9, 2025, with an ultimate completion date of November 10, 2025, utilizes firm fixed pricing with no set-aside designation. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen's extensive portfolio of federal medical contracts demonstrates its critical role in supplying pharmaceuticals and medical supplies to Defense Health Agency and other government healthcare systems. The company's federal awards encompass a wide spectrum of medical commodities including brand-name and generic medications, vaccines, specialty pharmaceuticals, and medical devices across multiple therapeutic domains. This delivery order continues the contractor's established relationship with the DLA, leveraging the existing prime vendor contract to fulfill federal medical procurement requirements for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 11/9/25 |